PT2306202E - Método para detectar ou para monitorizar no plasma uma doença celular maligna - Google Patents

Método para detectar ou para monitorizar no plasma uma doença celular maligna Download PDF

Info

Publication number
PT2306202E
PT2306202E PT101962496T PT10196249T PT2306202E PT 2306202 E PT2306202 E PT 2306202E PT 101962496 T PT101962496 T PT 101962496T PT 10196249 T PT10196249 T PT 10196249T PT 2306202 E PT2306202 E PT 2306202E
Authority
PT
Portugal
Prior art keywords
detecting
immunoglobulins
bound
monitoring
plasma
Prior art date
Application number
PT101962496T
Other languages
English (en)
Portuguese (pt)
Inventor
Arthur Bradwell
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Publication of PT2306202E publication Critical patent/PT2306202E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G01N33/57505—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT101962496T 2005-01-27 2006-01-26 Método para detectar ou para monitorizar no plasma uma doença celular maligna PT2306202E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody

Publications (1)

Publication Number Publication Date
PT2306202E true PT2306202E (pt) 2014-02-27

Family

ID=34259791

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101962496T PT2306202E (pt) 2005-01-27 2006-01-26 Método para detectar ou para monitorizar no plasma uma doença celular maligna

Country Status (11)

Country Link
US (3) US7897353B2 (cg-RX-API-DMAC7.html)
EP (2) EP2306202B1 (cg-RX-API-DMAC7.html)
JP (3) JP5431674B2 (cg-RX-API-DMAC7.html)
AT (1) ATE502302T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006020688D1 (cg-RX-API-DMAC7.html)
DK (1) DK2306202T3 (cg-RX-API-DMAC7.html)
ES (2) ES2365626T7 (cg-RX-API-DMAC7.html)
GB (1) GB0501741D0 (cg-RX-API-DMAC7.html)
PL (1) PL2306202T3 (cg-RX-API-DMAC7.html)
PT (1) PT2306202E (cg-RX-API-DMAC7.html)
WO (1) WO2006079816A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
EP2414399A1 (en) 2009-04-01 2012-02-08 F. Hoffmann-La Roche AG Anti-fcrh5 antibodies and immunoconjugates and methods of use
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
US9550004B2 (en) 2013-09-06 2017-01-24 Sensor Electronic Technology, Inc. Ultraviolet diffusive illumination
AU2015240454B2 (en) 2014-04-04 2019-08-22 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
US12153052B2 (en) 2017-09-13 2024-11-26 Mayo Foundation For Medical Education And Research Identification and monitoring of immunoglobulin J chains
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) * 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
JPS57501147A (cg-RX-API-DMAC7.html) 1980-07-16 1982-07-01
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
ES2184734T3 (es) 1987-04-27 2003-04-16 Inverness Medical Switzerland Dispositivo de prueba analitica para realizar ensayos de union especifica.
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
WO1997017372A1 (en) 1995-11-03 1997-05-15 The Binding Site Limited Production of antibodies, and medical uses involving antibodies
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
CA2349290A1 (en) * 1998-11-19 2000-06-02 Elan Corporation, Plc Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
IL157165A0 (en) * 2001-02-20 2004-02-08 Genset Sa Pg-3 and biallelic markers thereof
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
JPWO2003046009A1 (ja) * 2001-11-27 2005-04-07 持田製薬株式会社 抗ＩＬ１３レセプターα１中和抗体
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
EP2343315A3 (en) * 2003-02-10 2011-11-23 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US7662387B2 (en) * 2003-02-20 2010-02-16 Seattle Genetics Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
JP4473257B2 (ja) * 2003-04-02 2010-06-02 エフ．ホフマン−ラ ロシュ アーゲー インスリン様成長因子ｉ受容体に対する抗体及びその使用
WO2005062044A1 (ja) * 2003-11-19 2005-07-07 Yamasa Corporation ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
US8592561B2 (en) 2013-11-26
JP2008528995A (ja) 2008-07-31
JP2013147499A (ja) 2013-08-01
EP1842071B1 (en) 2011-03-16
DK2306202T3 (da) 2014-02-10
US20110177977A1 (en) 2011-07-21
EP1842071A1 (en) 2007-10-10
PL2306202T3 (pl) 2014-05-30
ATE502302T1 (de) 2011-04-15
DE602006020688D1 (de) 2011-04-28
JP5715671B2 (ja) 2015-05-13
US20080166742A1 (en) 2008-07-10
ES2455440T3 (es) 2014-04-15
US8415110B2 (en) 2013-04-09
EP1842071B3 (en) 2014-02-26
JP2014025950A (ja) 2014-02-06
GB0501741D0 (en) 2005-03-02
JP6007134B2 (ja) 2016-10-12
ES2365626T7 (es) 2014-06-04
ES2365626T3 (es) 2011-10-07
US7897353B2 (en) 2011-03-01
WO2006079816A1 (en) 2006-08-03
EP2306202B1 (en) 2013-12-18
JP5431674B2 (ja) 2014-03-05
EP2306202A1 (en) 2011-04-06
US20110177535A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
PT2306202E (pt) Método para detectar ou para monitorizar no plasma uma doença celular maligna
ATE410684T1 (de) Molekular-modifikations-assays
ATE449337T1 (de) Assay
WO2009058902A3 (en) Methods and devices for analyte detection
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
ATE446972T1 (de) Il-1 bindende antikörper und fragmente davon
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
WO2008007242A3 (en) Increased specificity of analyte detection by measurement of bound and unbound labels
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
DK1752471T3 (da) Syntetiske immunoglogulindomæner med bindende egenskaber, der er modificerede i områder af molekylet, og som adskiller sig fra de komplementaritetsbestemmende områder
WO2008082984A3 (en) Non-denaturing lysis reagent for use with capture-in-solution immunoassay
WO2008118558A3 (en) Improved antibody profiling sensitivity through increased reporter antibody layering
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
WO2010049672A3 (en) Methods and products for measuring free immunoglobulin light chain molecules
DE60013320D1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
WO2008101177A3 (en) Ige antibodies to chimeric or humanized igg therapeutic monoclonal antibodies as a screening test for anaphylaxis
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2008076367A3 (en) Polymer-protein substrates for immunosorbent fluorescence assays
WO2001073443A3 (en) Methods and compositions for the simultaneous detection of multiple analytes
JP2008528995A5 (cg-RX-API-DMAC7.html)
ATE405837T1 (de) Festphase immunochromatographische testverfahren
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
WO2007001895A3 (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
WO2002079783A3 (en) Method and device for testing for bence-jones protein
AU2003248619A1 (en) Method for the elimination of interferences in immunochromatographic assays